SGMT
Sagimet Biosciences Inc.
Recent 8-K filings for SGMT
Each filing is summarized by an LLM — headline, three bullets, event type. The source document on EDGAR is one click away. See methodology.
-
May 12, 2026 11:35 UTC earnings item 2.02item 9.01
Sagimet Q1 net loss $10.7M; $175M April financing; Phase 3 acne trial H2 2026
source · SGMT on sec.gov